Total Nutraceutical Solutions Inc. (TNS), a leading mushroom-for-nutrition research and development company, today announced a revenue sharing agreement between itself, California-based AMC LLC, and Hong Kong-based Delta Group Investments Ltd.
Per the agreement, the parties will conduct a direct mail marketing program for a proprietary private label compound for joint pain and inflammation developed and manufactured by TNS.
“This agreement allows our company to effectively formulate and launch proprietary dietary supplement products into the United States market,” Marvin S. Hausman MD, CEO of TNS stated in the press release. “TNS has become a global leader in the research and development of mushroom-based products and enrichment processes for potent antioxidants such as L-Ergothioneine and Vitamin D2. Our company intends to actively formulate and launch into the U.S. and International dietary supplement markets breakthrough nutritional products enriched with these key nutrients that have the potential to improve human health and well-being.”
AMC is experienced in direct mail marketing and has focused on the nutraceutical industry for the last 20 years. AMC and its predecessor achieved sales of more than $140.0 million in the nutraceutical industry during one four-year period. As part of the agreement, AMC will receive stock purchase warrants contingent on the performance of total sales.
DGI is a private investment company offering a loan of $300,000 of operating capital to test and launch the companies’ direct mail marketing campaign. DGI has the option to convert the loan to common stock of TNS at $0.25 per share.
Initial testing of the mailing consists of 250,000 pieces, which will be sent out on or about April 30, 2010.